This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
adjective | noun | frequency |
---|---|---|
immune | response | 1876 |
immune | responses | 1863 |
- | cell | 923 |
clinical | trials | 881 |
infectious | diseases | 709 |
immune | system | 667 |
protective | immunity | 447 |
clinical | trial | 431 |
humans | . | 291 |
infectious | disease | 280 |
new | vaccines | 210 |
viral | vectors | 208 |
new | vaccine | 197 |
- | virus | 174 |
viral | vector | 166 |
- | vaccination | 159 |
live | vaccines | 146 |
- | cells | 145 |
- | vaccine | 144 |
available | . | 143 |
clinical | development | 143 |
recombinant | protein | 141 |
immune | cells | 140 |
effective | vaccine | 139 |
mucosal | immunity | 139 |
attenuated | vaccines | 139 |
clinical | studies | 139 |
- | protein | 137 |
respiratory | disease | 132 |
effective | vaccines | 126 |
viral | infection | 124 |
specific | antibodies | 122 |
live | virus | 119 |
attenuated | vaccine | 114 |
clinical | disease | 114 |
viral | infections | 113 |
viral | proteins | 107 |
live | vaccine | 107 |
oral | vaccine | 106 |
severe | disease | 103 |
potential | vaccine | 102 |
oral | vaccines | 100 |
recombinant | proteins | 94 |
oral | immunization | 93 |
viral | diseases | 91 |
human | vaccines | 88 |
mucosal | vaccine | 86 |
respiratory | viruses | 84 |
other | vaccines | 83 |
recombinant | vaccine | 83 |
such | vaccines | 83 |
recombinant | vaccines | 80 |
- | infection | 77 |
viral | vaccines | 77 |
- | protection | 75 |
oral | vaccination | 75 |
- | antigen | 74 |
attenuated | virus | 69 |
attenuated | influenza | 68 |
human | use | 67 |
other | vaccine | 67 |
others | . | 66 |
specific | antibody | 66 |
human | influenza | 65 |
mucosal | adjuvants | 64 |
respiratory | virus | 62 |
immune | protection | 59 |
viral | antigens | 58 |
respiratory | infections | 57 |
protective | antigen | 57 |
human | vaccine | 57 |
mucosal | vaccines | 55 |
viral | vaccine | 55 |
mucosal | adjuvant | 54 |
effective | . | 53 |
protective | antibody | 53 |
- | vaccines | 51 |
protective | antigens | 51 |
human | trials | 50 |
viral | disease | 49 |
viral | protein | 49 |
other | studies | 47 |
- | dna | 46 |
- | influenza | 46 |
recombinant | viruses | 46 |
human | disease | 45 |
human | infection | 44 |
many | vaccines | 43 |
recombinant | virus | 43 |
immune | systems | 42 |
human | infections | 41 |
important | . | 41 |
different | vaccine | 41 |
- | vector | 41 |
clinical | study | 41 |
available | vaccines | 40 |
other | diseases | 39 |
new | adjuvants | 38 |
recombinant | dna | 38 |
clinical | use | 37 |
viral | antigen | 36 |
mucosal | vaccination | 35 |
potential | . | 34 |
several | studies | 34 |
protective | antibodies | 34 |
other | viruses | 34 |
human | cells | 34 |
first | vaccine | 34 |
several | vaccine | 33 |
specific | antigens | 33 |
- | antibody | 31 |
- | immunization | 31 |
infectious | virus | 31 |
viral | genes | 31 |
specific | immunity | 30 |
respiratory | diseases | 30 |
human | studies | 30 |
different | antigens | 30 |
human | antibody | 29 |
low | . | 29 |
different | vaccines | 29 |
attenuated | viruses | 28 |
mucosal | immunization | 28 |
new | influenza | 28 |
specific | antigen | 28 |
higher | antibody | 27 |
severe | influenza | 27 |
potential | use | 26 |
protective | response | 26 |
- | adjuvant | 26 |
many | studies | 26 |
such | studies | 25 |
- | use | 24 |
recombinant | influenza | 24 |
recombinant | vector | 24 |
respiratory | infection | 24 |
specific | vaccine | 24 |
high | . | 23 |
new | virus | 23 |
specific | vaccines | 23 |
- | sars | 23 |
immune | cell | 23 |
- | proteins | 22 |
high | antibody | 22 |
human | cell | 22 |
mucosal | antibody | 22 |
other | animal | 22 |
protective | responses | 22 |
recombinant | antigen | 22 |
- | antigens | 22 |
many | diseases | 21 |
other | animals | 21 |
different | adjuvants | 21 |
effective | vaccination | 21 |
first | vaccination | 20 |
high | vaccination | 20 |
potential | vaccines | 20 |
live | viruses | 19 |
new | developments | 19 |
several | vaccines | 18 |
recombinant | sars | 18 |
human | viruses | 18 |
- | response | 18 |
clinical | protection | 17 |
different | animal | 17 |
human | trial | 17 |
live | influenza | 17 |
other | . | 17 |
other | antigens | 17 |
several | diseases | 17 |
viral | dna | 17 |
recombinant | antigens | 16 |
viral | gene | 16 |
human | antibodies | 16 |
many | vaccine | 16 |
large | animals | 16 |
- | infections | 15 |
human | diseases | 15 |
new | antigens | 15 |
other | adjuvants | 15 |
other | genes | 15 |
recombinant | vectors | 15 |
new | vaccination | 14 |
protective | . | 14 |
- | immunity | 14 |
lower | vaccine | 14 |
effective | immunization | 14 |
mucosal | antibodies | 13 |
specific | responses | 13 |
specific | disease | 13 |
specific | . | 13 |
protective | vaccine | 13 |
mucosal | response | 13 |
many | viruses | 13 |
higher | antigen | 13 |
high | vaccine | 13 |
effective | adjuvant | 13 |
available | vaccine | 13 |
- | viruses | 13 |
- | gene | 13 |
specific | cell | 12 |
such | vaccine | 12 |
specific | virus | 12 |
respiratory | system | 12 |
different | viruses | 12 |
different | influenza | 12 |
low | antibody | 11 |
specific | response | 11 |
potential | sars | 11 |
newer | vaccines | 11 |
low | vaccine | 11 |
mucosal | infections | 11 |
immune | adjuvants | 11 |
human | sars | 11 |
first | used | 11 |
different | virus | 11 |
clinical | vaccine | 11 |
first | study | 10 |
other | virus | 10 |
other | cells | 10 |
important | diseases | 10 |
higher | . | 10 |
first | vaccines | 10 |
immune | adjuvant | 10 |
effective | use | 10 |
- | animal | 10 |
different | . | 10 |
- | mouse | 10 |
- | antibodies | 10 |
effective | protection | 10 |
mucosal | responses | 9 |
severe | infection | 9 |
other | influenza | 9 |
new | disease | 9 |
new | adjuvant | 9 |
large | . | 9 |
infectious | viruses | 9 |
human | virus | 9 |
high | immunization | 9 |
- | development | 9 |
new | infections | 8 |
such | systems | 8 |
such | diseases | 8 |
specific | protein | 8 |
specific | adjuvants | 8 |
several | animal | 8 |
potential | adjuvants | 8 |
other | infections | 8 |
other | cell | 8 |
live | vectors | 8 |
mucosal | disease | 8 |
large | animal | 8 |
important | disease | 8 |
human | vaccination | 8 |
high | protection | 8 |
high | antigen | 8 |
effective | influenza | 8 |
many | proteins | 8 |
several | antigens | 7 |
other | systems | 7 |
potential | antigens | 7 |
protective | vaccines | 7 |
specific | proteins | 7 |
several | viruses | 7 |
oral | dna | 7 |
specific | cells | 7 |
such | antibodies | 7 |
other | proteins | 7 |
severe | . | 7 |
new | antigen | 7 |
human | . | 7 |
higher | vaccine | 7 |
effective | sars | 7 |
effective | immunity | 7 |
effective | dna | 7 |
effective | antigen | 7 |
different | studies | 7 |
different | cell | 7 |
low | antigen | 7 |
recombinant | genes | 6 |
mucosal | protection | 6 |
mucosal | system | 6 |
new | studies | 6 |
other | gene | 6 |
such | viruses | 6 |
several | adjuvants | 6 |
several | proteins | 6 |
severe | infections | 6 |
such | trials | 6 |
lower | . | 6 |
many | antigens | 6 |
new | diseases | 6 |
larger | studies | 6 |
higher | virus | 6 |
- | mice | 6 |
important | vaccine | 6 |
- | studied | 6 |
clinical | responses | 6 |
different | vaccination | 6 |
different | adjuvant | 6 |
human | gene | 6 |
human | responses | 6 |
human | study | 6 |
immune | . | 6 |
immune | genes | 6 |
other | adjuvant | 5 |
human | dna | 5 |
human | immunity | 5 |
important | development | 5 |
large | antigens | 5 |
live | vector | 5 |
low | vaccination | 5 |
lower | influenza | 5 |
specific | influenza | 5 |
other | disease | 5 |
potential | vaccination | 5 |
protective | influenza | 5 |
protective | vaccination | 5 |
several | genes | 5 |
specific | protection | 5 |
such | infections | 5 |
higher | protection | 5 |
human | animals | 5 |
effective | response | 5 |
high | disease | 5 |
different | sars | 5 |
high | cell | 5 |
- | adjuvants | 5 |
- | disease | 5 |
- | study | 5 |
- | used | 5 |
attenuated | vector | 5 |
different | genes | 5 |
- | trial | 5 |
different | trials | 5 |
effective | antibody | 5 |
effective | disease | 5 |
first | . | 5 |
first | immunization | 5 |
first | influenza | 5 |
effective | adjuvants | 5 |
first | sars | 5 |
other | sars | 4 |
protective | immunizations | 4 |
potential | vector | 4 |
other | vaccination | 4 |
other | trials | 4 |
new | viruses | 4 |
oral | infection | 4 |
oral | immunizations | 4 |
new | vector | 4 |
several | dna | 4 |
recombinant | gene | 4 |
such | vectors | 4 |
severe | diseases | 4 |
specific | adjuvant | 4 |
specific | dna | 4 |
specific | genes | 4 |
specific | vaccination | 4 |
mucosal | dna | 4 |
such | adjuvants | 4 |
such | cells | 4 |
such | virus | 4 |
viral | immunity | 4 |
new | development | 4 |
such | . | 4 |
mucosal | cells | 4 |
high | virus | 4 |
many | adjuvants | 4 |
available | influenza | 4 |
available | protection | 4 |
clinical | influenza | 4 |
different | diseases | 4 |
different | proteins | 4 |
first | gene | 4 |
first | use | 4 |
high | infection | 4 |
high | protein | 4 |
different | protein | 4 |
highest | antibody | 4 |
large | vaccine | 4 |
human | immunization | 4 |
lower | antibody | 4 |
lived | immunity | 4 |
live | sars | 4 |
larger | trials | 4 |
important | viruses | 4 |
important | virus | 4 |
human | proteins | 4 |
human | protein | 4 |
protective | immunization | 3 |
other | vaccinations | 3 |
potential | influenza | 3 |
potential | disease | 3 |
potential | adjuvant | 3 |
other | vectors | 3 |
new | study | 3 |
other | system | 3 |
other | study | 3 |
oral | protein | 3 |
newer | vaccine | 3 |
newer | adjuvants | 3 |
recombinant | antibodies | 3 |
protective | virus | 3 |
such | development | 3 |
recombinant | antibody | 3 |
recombinants | . | 3 |
recombinants | using | 3 |
several | protein | 3 |
several | sars | 3 |
severe | sars | 3 |
specific | gene | 3 |
specific | sars | 3 |
specific | use | 3 |
specific | viruses | 3 |
such | antigens | 3 |
new | cell | 3 |
such | vaccination | 3 |
viral | cell | 3 |
new | immunization | 3 |
potential | protein | 3 |
mucosal | virus | 3 |
immune | animals | 3 |
mucosal | antigen | 3 |
- | vectors | 3 |
available | sars | 3 |
clinical | infection | 3 |
different | mouse | 3 |
different | vector | 3 |
different | vectors | 3 |
effective | antibodies | 3 |
effective | responses | 3 |
effective | vector | 3 |
higher | responses | 3 |
highest | . | 3 |
human | genes | 3 |
human | response | 3 |
different | responses | 3 |
immune | diseases | 3 |
live | . | 3 |
many | virus | 3 |
immune | studies | 3 |
many | vaccination | 3 |
many | systems | 3 |
many | animal | 3 |
many | . | 3 |
many | disease | 3 |
larger | animals | 3 |
large | trials | 3 |
large | studies | 3 |
large | dna | 3 |
important | infections | 3 |
potential | antigen | 2 |
new | vectors | 2 |
potential | animal | 2 |
others | using | 2 |
others | used | 2 |
other | vector | 2 |
potential | infection | 2 |
other | protein | 2 |
other | antibodies | 2 |
oral | influenza | 2 |
oral | adjuvant | 2 |
mucosal | cell | 2 |
new | uses | 2 |
new | sars | 2 |
new | animal | 2 |
new | . | 2 |
mucosal | infection | 2 |
many | infections | 2 |
many | genes | 2 |
many | cells | 2 |
lowest | vaccine | 2 |
potential | vectors | 2 |
lowest | . | 2 |
potential | protection | 2 |
such | antibody | 2 |
potential | virus | 2 |
specific | infections | 2 |
lower | protection | 2 |
viral | response | 2 |
viral | influenza | 2 |
viral | antibodies | 2 |
such | system | 2 |
such | study | 2 |
such | proteins | 2 |
such | protection | 2 |
such | immunity | 2 |
such | adjuvant | 2 |
specific | immunization | 2 |
protective | proteins | 2 |
specific | diseases | 2 |
severe | protein | 2 |
several | virus | 2 |
several | trials | 2 |
several | mouse | 2 |
several | influenza | 2 |
respiratory | protection | 2 |
respiratory | influenza | 2 |
recombinant | systems | 2 |
recombinant | mouse | 2 |
lower | virus | 2 |
new | genes | 2 |
lower | antigen | 2 |
higher | influenza | 2 |
higher | cell | 2 |
high | vector | 2 |
high | sars | 2 |
first | virus | 2 |
first | vaccinations | 2 |
first | studies | 2 |
first | infection | 2 |
different | systems | 2 |
different | study | 2 |
different | gene | 2 |
different | disease | 2 |
different | antigen | 2 |
different | antibody | 2 |
clinical | sars | 2 |
clinical | infections | 2 |
available | animal | 2 |
attenuated | . | 2 |
- | vaccinations | 2 |
- | system | 2 |
- | responses | 2 |
- | genes | 2 |
- | diseases | 2 |
low | influenza | 2 |
higher | gene | 2 |
different | immunization | 2 |
higher | vaccination | 2 |
important | vector | 2 |
larger | study | 2 |
highest | protein | 2 |
larger | proteins | 2 |
large | trial | 2 |
large | study | 2 |
large | response | 2 |
large | proteins | 2 |
large | gene | 2 |
large | antigen | 2 |
infectious | . | 2 |
large | protein | 2 |
important | vaccines | 2 |
important | study | 2 |
highest | response | 2 |
important | developments | 2 |
important | animals | 2 |
humans | using | 2 |
human | development | 2 |
human | animal | 2 |
largest | vaccine | 2 |
highest | vaccine | 2 |
new | antibodies | 1 |
new | mouse | 1 |
new | infection | 1 |
new | dna | 1 |
mucosal | protein | 1 |
mucosal | vaccinations | 1 |
mucosal | systems | 1 |
mucosal | sars | 1 |
new | systems | 1 |
mucosal | immunities | 1 |
new | proteins | 1 |
other | antibody | 1 |
newer | diseases | 1 |
newer | vaccination | 1 |
newest | system | 1 |
newest | vaccine | 1 |
oral | antigen | 1 |
oral | antigens | 1 |
oral | disease | 1 |
oral | gene | 1 |
oral | infections | 1 |
other | antigen | 1 |
other | dna | 1 |
many | trials | 1 |
mucosal | diseases | 1 |
low | disease | 1 |
many | sars | 1 |
lower | immunization | 1 |
living | viruses | 1 |
low | antibodies | 1 |
potential | antibody | 1 |
low | gene | 1 |
low | immunization | 1 |
low | infection | 1 |
low | response | 1 |
low | responses | 1 |
low | trial | 1 |
low | virus | 1 |
lower | dna | 1 |
lower | protein | 1 |
many | immunizations | 1 |
lower | response | 1 |
lower | sars | 1 |
lowest | protection | 1 |
lowest | protein | 1 |
lows | . | 1 |
many | animals | 1 |
many | antibodies | 1 |
many | cell | 1 |
many | development | 1 |
many | dna | 1 |
many | gene | 1 |
other | mouse | 1 |
respiratory | vaccines | 1 |
potential | cell | 1 |
several | development | 1 |
several | gene | 1 |
several | responses | 1 |
several | systems | 1 |
several | vaccination | 1 |
specific | animal | 1 |
specific | immunizations | 1 |
specific | infection | 1 |
specific | mouse | 1 |
specific | protections | 1 |
such | animals | 1 |
such | antigen | 1 |
such | cell | 1 |
such | disease | 1 |
such | dna | 1 |
such | genes | 1 |
such | mouse | 1 |
such | protein | 1 |
such | response | 1 |
viral | protection | 1 |
viral | responses | 1 |
viral | systems | 1 |
viral | vaccination | 1 |
lived | vaccine | 1 |
several | disease | 1 |
several | cell | 1 |
potential | development | 1 |
several | antigen | 1 |
potential | diseases | 1 |
potential | dna | 1 |
potential | gene | 1 |
potential | genes | 1 |
potential | systems | 1 |
potential | uses | 1 |
potentials | . | 1 |
potentials | vaccination | 1 |
protective | cell | 1 |
protective | dna | 1 |
protective | gene | 1 |
protective | protein | 1 |
recombinant | . | 1 |
recombinant | cell | 1 |
recombinant | immunization | 1 |
recombinant | studies | 1 |
recombinant | system | 1 |
respiratory | cell | 1 |
respiratory | sars | 1 |
respiratory | systems | 1 |
respiratory | vaccination | 1 |
respiratory | vaccine | 1 |
several | . | 1 |
lives | . | 1 |
available | studies | 1 |
lived | responses | 1 |
first | antigen | 1 |
different | infections | 1 |
different | protection | 1 |
different | use | 1 |
effective | development | 1 |
effective | protein | 1 |
effective | proteins | 1 |
effective | vaccinations | 1 |
effective | vectors | 1 |
effective | virus | 1 |
first | animal | 1 |
first | antibody | 1 |
first | cell | 1 |
lived | protection | 1 |
first | disease | 1 |
first | diseases | 1 |
first | dna | 1 |
first | mouse | 1 |
first | response | 1 |
first | studied | 1 |
first | trial | 1 |
first | trials | 1 |
first | vector | 1 |
high | development | 1 |
high | influenza | 1 |
different | infection | 1 |
different | dna | 1 |
different | cells | 1 |
different | antibodies | 1 |
- | diseased | 1 |
- | systems | 1 |
- | using | 1 |
attenuated | antigens | 1 |
attenuated | infection | 1 |
attenuated | sars | 1 |
attenuated | vaccination | 1 |
attenuated | vectors | 1 |
available | adjuvants | 1 |
available | antigen | 1 |
available | development | 1 |
available | disease | 1 |
available | dna | 1 |
available | protein | 1 |
available | using | 1 |
clinical | animal | 1 |
clinical | developments | 1 |
clinical | immunity | 1 |
clinical | response | 1 |
clinical | vaccination | 1 |
clinical | vectors | 1 |
clinical | virus | 1 |
different | animals | 1 |
higher | animal | 1 |
higher | disease | 1 |
higher | immunity | 1 |
infectious | vaccine | 1 |
infectious | vector | 1 |
large | cell | 1 |
large | disease | 1 |
large | vaccination | 1 |
large | vector | 1 |
large | virus | 1 |
large | viruses | 1 |
larger | animal | 1 |
larger | antigen | 1 |
larger | gene | 1 |
larger | trial | 1 |
larger | vaccine | 1 |
largest | disease | 1 |
largest | trial | 1 |
largest | viruses | 1 |
live | animal | 1 |
live | cells | 1 |
live | system | 1 |
live | vaccination | 1 |
live | vaccinations | 1 |
lived | . | 1 |
lived | antibodies | 1 |
lived | antibody | 1 |
infectious | vaccines | 1 |
infectious | systems | 1 |
higher | immunization | 1 |
infectious | sars | 1 |
higher | protein | 1 |
highest | influenza | 1 |
highest | protection | 1 |
highest | vaccination | 1 |
human | adjuvants | 1 |
human | antigen | 1 |
humans | sars | 1 |
immune | antigens | 1 |
immune | mice | 1 |
immune | proteins | 1 |
important | adjuvant | 1 |
important | antigen | 1 |
important | antigens | 1 |
important | genes | 1 |
important | immunization | 1 |
important | infection | 1 |
important | influenza | 1 |
important | systems | 1 |
important | use | 1 |
important | vaccination | 1 |
infectious | cells | 1 |
infectious | influenza | 1 |
infectious | responses | 1 |
virals | . | 1 |